Akt1 and -2 inhibition diminishes terminal differentiation and enhances central memory CD8+T-cell proliferation and survival

Cutting Edge: Foxp3-Mediated Induction of Pim 2 Allows Human T Regulatory Cells to Preferentially Expand in Rapamycin

(2014) Samik Basu et al.   JOURNAL OF IMMUNOLOGY

Blockade of mTOR Signaling via Rapamycin Combined with Immunotherapy Augments Antiglioma Cytotoxic and Memory T-Cell Functions

(2014) Y. Mineharu et al.   MOLECULAR CANCER THERAPEUTICS

Selective Inhibition of Regulatory T Cells by Targeting the PI3K-Akt Pathway

(2014) R. Abu-Eid et al.   Cancer Immunology Research

Antibody-based depletion of Foxp3+ T cells potentiates antitumor immune memory stimulated by mTOR inhibition

(2014) Hyung L Kim   OncoImmunology

Role of PI3K/Akt signaling in memory CD8 T cell differentiation

(2013) Eui Ho Kim et al.   Frontiers in Immunology

Regulating Mammalian Target of Rapamycin To Tune Vaccination-Induced CD8+ T Cell Responses for Tumor Immunity

(2012) Q. Li et al.   JOURNAL OF IMMUNOLOGY

Signal Integration by Akt Regulates CD8 T Cell Effector and Memory Differentiation

(2012) E. H. Kim et al.   JOURNAL OF IMMUNOLOGY

Phosphoinositide 3-kinase and the mammalian target of rapamycin pathways control T cell migration

(2010) David Finlay et al.   Annals of the New York Academy of Sciences

Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy

(2010) C. S. Hinrichs et al.   BLOOD

mTOR regulates memory CD8 T-cell differentiation

(2009) Koichi Araki et al.   NATURE

Combination of rapamycin and IL-2 increases de novo induction of human CD4+CD25+FOXP3+ T cells

(2008) S. Alice Long et al.   JOURNAL OF AUTOIMMUNITY